SPRINTER LONG - ASTRAZENECA Share Price

Certificat

U534G

NL0010744041

Real-time Euronext Paris 09:00:00 20/05/2024 pm IST
124 ^EUR	+0.10%

Current month	+0.46%
1 month	+12.46%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart ASTRAZENECA PLC

Latest news about ASTRAZENECA PLC

AstraZeneca drug lowers cholesterol in phase 1 trial	01:26pm	AN
Cellectis: operations financed until 2026	01:16pm	CF
Astrazeneca Says AZD0780 Demonstrated Significant LDL-C Reduction On Top Of Statin In Phase I Trial	11:36am	RE
US FDA approves Amgen's biosimilar to AstraZeneca's rare blood disorder treatment	29/05	RE

More news

Static data

Product type	Knock-Out mit Stop Loss
Buy / Sell	CALL
Underlying	ASTRAZENECA PLC
Issuer	ING Bank
	U534G
ISIN	NL0010744041
Date issued	20/05/2014
Strike	1,491 p
Maturity	Unlimited
Parity	1 : 1
Emission price	- €
Emission volume	N/A
Settlement	Barausgleich
Currency	EUR

Technical Indicators

Highest since issue	127.2 €
Lowest since issue	92.33 €

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).

Sector

More about the company